Biogen reported $7.27B in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
ALKERMES ALKS:US 294.07M 632K
Amgen AMGN:US $ 28458M 2671M
Bayer BAYN:GR € 36664M 1254M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Eli Lilly And LLY:US $ 14736.6M 1463M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Moderna Inc MRNA:US $ 328M 190M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NOVN:VX SF 26491M 908M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Puma Biotechnology PBYI:US $ 68.71M 7.64M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 21.6B 686M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 31.84M 0.32M